Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Disruption of ATR Signaling by Epstein–Barr Virus Latent Membrane Protein 1 Sensitizes Nasopharyngeal Carcinoma Cells to Cisplatin

Journal of Medical Virology(2025)10.1002/jmv.70407Source: DataRank Database

Disruption of ATR Signaling by Epstein–Barr Virus Latent Membrane Protein 1 Sensitizes Nasopharyngeal Carcinoma Cells to Cisplatin is a research paper published in Journal of Medical Virology (2025). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 1.91)OA: hybridTopics (46)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Phillip Ziegler ORCID,Jennifer Hye‐Rim Lee ORCID,Brooke P. Dresden ORCID,Amit Kumar ORCID,Masahiro Shuda ORCID

Live enrichment

PubMed:40407079 PMC:PMC12100692 OpenAlex:https://openalex.org/W4410622501

NCI NIH HHS

Grant: P30 CA047904

National Institutes of Health

Grant: 3P30CA047904-07S1

CANCER CENTER SUPPORT GRANT

This study was supported by the American Cancer Society RSG-16-050-01-MPC (to K.H.Y. Shair) and the UPMC Hillman Cancer Center shared resources supported by the National Cancer Institute of the National Institutes of Health under Award Number P30CA047904.

FWCI

1.91

Citation Percentile

0.9%

Citation Trend

2025

2026

hybridLicense: cc-by-nc

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jmv.70407

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jmv.70407

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.70407

journalhttps://doi.org/10.1002/jmv.70407

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40407079

Fields of Study

Viral-associated cancers and disordersPolyomavirus and related diseasesHistiocytic Disorders and Treatments0301 basic medicine03 medical and health sciences

MeSH Terms

Nasopharyngeal CarcinomaAntineoplastic AgentsCisplatinDNA DamageHerpesvirus 4, HumanHumansNasopharyngeal NeoplasmsViral Matrix ProteinsSignal TransductionEpstein-Barr Virus InfectionsCell Line, TumorCell Cycle CheckpointsAtaxia Telangiectasia Mutated Proteins

Keywords

Nasopharyngeal carcinomaCisplatinCancer researchGene knockdownBiologyCell cultureVirologyEpstein–Barr virusVirusImmunologyMedicineChemotherapyInternal medicineGeneticsLatent membrane protein 1Dna Damage Response SignalingHerpesvirus 4, HumanEpstein-Barr Virus InfectionsAntineoplastic AgentsNasopharyngeal NeoplasmsAtaxia Telangiectasia Mutated ProteinsCell Cycle CheckpointsViral Matrix ProteinsCell Line, TumorHumansResearch ArticleSignal TransductionDNA Damage

Sustainable Development Goals

SDG 0: Good health and well-being